Literature DB >> 26634029

A New Differential Diagnosis: Synthetic Cannabinoids-Associated Acute Renal Failure.

Vineet S Gudsoorkar1, Jose A Perez1.   

Abstract

Synthetic cannabinoids (SCs) are herbal blends that use plant material with varying concentrations of synthetic analogues of cannabinoids. These products are sold as incense or potpourri and are labeled "Not for human use." Even so, rates of abuse are rapidly increasing worldwide, especially in the young adult population. An extensive network of users exists, and the products can easily be ordered on the Internet under various brand names, including the most popular ones, "K2" and "Spice." Not much is known about their spectrum of toxicity and no specific antidote is available at present. Renal failure is a rare complication associated with SC abuse. We describe a case of acute kidney injury associated with use of SCs and present a review of the current literature, including the history and some key pharmacologic and epidemiologic findings related to synthetic cannabinoid compounds.

Entities:  

Keywords:  Spice; acute kidney injury; synthetic cannabionoid

Mesh:

Substances:

Year:  2015        PMID: 26634029      PMCID: PMC4666428          DOI: 10.14797/mdcj-11-3-189

Source DB:  PubMed          Journal:  Methodist Debakey Cardiovasc J        ISSN: 1947-6108


  5 in total

Review 1.  Here today, gone tomorrow…and back again? A review of herbal marijuana alternatives (K2, Spice), synthetic cathinones (bath salts), kratom, Salvia divinorum, methoxetamine, and piperazines.

Authors:  Christopher D Rosenbaum; Stephanie P Carreiro; Kavita M Babu
Journal:  J Med Toxicol       Date:  2012-03

Review 2.  A brief history of cannabinoid and endocannabinoid pharmacology as inspired by the work of British scientists.

Authors:  Vincenzo Di Marzo
Journal:  Trends Pharmacol Sci       Date:  2006-02-13       Impact factor: 14.819

3.  Synthetic cannabinoid use associated with acute kidney injury.

Authors:  Stephen L Thornton; Clayton Wood; Matthew W Friesen; Roy R Gerona
Journal:  Clin Toxicol (Phila)       Date:  2013-03       Impact factor: 4.467

4.  AKI associated with synthetic cannabinoids: a case series.

Authors:  Gautam Kantilal Bhanushali; Gaurav Jain; Huma Fatima; Leah J Leisch; Denyse Thornley-Brown
Journal:  Clin J Am Soc Nephrol       Date:  2012-12-14       Impact factor: 8.237

5.  Acute kidney injury associated with synthetic cannabinoid use--multiple states, 2012.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2013-02-15       Impact factor: 17.586

  5 in total
  12 in total

Review 1.  Herbal Nephropathy.

Authors:  Amita Jain; Juan Jose Olivero
Journal:  Methodist Debakey Cardiovasc J       Date:  2019 Jul-Sep

2.  What Should We Tell Our Patients About Marijuana (Cannabis indica and Cannabis sativa)?

Authors:  Joseph Pizzorno
Journal:  Integr Med (Encinitas)       Date:  2016-12

3.  Thrombotic microangiopathy associated with synthetic cannabinoid receptor agonists.

Authors:  Michael Karass; Savneek Chugh; Gabriela Andries; Aleksandra Mamorska-Dyga; John C Nelson; Praveen N Chander
Journal:  Stem Cell Investig       Date:  2017-05-26

Review 4.  Cannabinoid exposure during pregnancy and its impact on immune function.

Authors:  Catherine Dong; Jingwen Chen; Amy Harrington; K Yaragudri Vinod; Muralidhar L Hegde; Venkatesh L Hegde
Journal:  Cell Mol Life Sci       Date:  2018-10-29       Impact factor: 9.261

5.  Acute Rhabdomyolysis Following Synthetic Cannabinoid Ingestion.

Authors:  Demilade A Adedinsewo; Oluwaseun Odewole; Taylor Todd
Journal:  N Am J Med Sci       Date:  2016-06

6.  Fatal Mesenteric Ischemia Induced by Synthetic Cannabinoids: A Case Report and Literature Review.

Authors:  David Hakimian; Orr Tomer; Nurith Hiller; Samuel N Heyman; Sarah Israel
Journal:  Case Rep Emerg Med       Date:  2017-12-18

Review 7.  Systematic review of nephrotoxicity of drugs of abuse, 2005-2016.

Authors:  Kanaan Mansoor; Murad Kheetan; Saba Shahnawaz; Anna P Shapiro; Eva Patton-Tackett; Larry Dial; Gary Rankin; Prasanna Santhanam; Antonios H Tzamaloukas; Tibor Nadasdy; Joseph I Shapiro; Zeid J Khitan
Journal:  BMC Nephrol       Date:  2017-12-29       Impact factor: 2.388

Review 8.  Synthetic Cathinone and Cannabinoid Designer Drugs Pose a Major Risk for Public Health.

Authors:  Aviv M Weinstein; Paola Rosca; Liana Fattore; Edythe D London
Journal:  Front Psychiatry       Date:  2017-08-23       Impact factor: 4.157

9.  Should donors who have used marijuana be considered candidates for living kidney donation?

Authors:  David Ruckle; Mohamed Keheila; Benjamin West; Pedro Baron; Rafael Villicana; Braden Mattison; Alex Thomas; Jerry Thomas; Michael De Vera; Arputharaj Kore; Philip Wai; D Duane Baldwin
Journal:  Clin Kidney J       Date:  2018-11-15

Review 10.  Designer drugs: mechanism of action and adverse effects.

Authors:  Dino Luethi; Matthias E Liechti
Journal:  Arch Toxicol       Date:  2020-04-06       Impact factor: 5.153

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.